Novartis and MMV launches patient trial in Africa for KAF156
KAF156 is first compound from the imidazolopiperazines, a novel class of antimalarials, to enter phase IIb combination studies
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
FDC seeks opportunities in untapped markets to boost revenue
The company will be ready to supply current market requirement of IMS with spare capacity
DuPont’s expands probiotics facility in Madison
New enhancements increase capability for rapidly developing and commercializing new probiotics with decreased time to market
Draft Pharmaceutical Policy 2017 calls for trade margins cap
Proposes ending 'unethical marketing practices' of pharmaceutical firms and marketing companies
ISPE 2017 Europe Pharma 4.0 Conference to be held in Italy
The conference will focus on preparing the pharma and biopharma industry for a full transition to an end-to-end integrated…
Abbott’s nutrition metabolic formulas to help infants diagnosed with IEM
Collaborates with healthcare providers, nutritionists and government to allow immediate availability, ensuring faster access to…
Suven Life Sciences bags patent for neuro-degenerative drug
The patents from Europe, Japan and New Zealand are valid till 2034
Piramal arm DRG acquires US firm Context Matters
New York-based Context Matters is in health economics data service, catering to the life sciences industry
PerkinElmer India opens centre of excellence at IISER Pune
The centre will help educate the region’s current and future scientists on high-throughput analyses in life sciences
Johnson & Johnson in partnership with CSIR-IMTECH
To develop innovative new tuberculosis treatments
DoP observes Swachhta Pakhwada
The department has involved various pharma and medical devices associations and their manufactures, traders, retailers and…
Biocon withdraws application for EU approval of two drugs
EU drugs regulator sought re-inspection of their production facility
Zydus Cadila receives US FDA approval for blood pressure drug
The drug will be manufactured at the groups formulations manufacturing facility at pharma SEZ in Ahmedabad
Suven’s revenue declines by 21 per cent
PAT was registered at Rs 295 million against Rs 403 million
Zydus settles patent case over Aptalis’ drug Canasa
Canasa is indicated to treat mildly to moderately active ulcerative colitis
Natco gets US FDA nod to market renal disease drug
The product, as the first generic, will be launched shortly in the US market
Over 1,000 Jan Aushadhi Kendras to open in UP
The shops will be opened under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme
Repeated regulatory reprimands will erode investor confidence in DRL: Analysts
German regulator's observations on GMP violations include systemic data integrity issues
Divis Labs bags green nod
To modernise its bulk drug unit in Visakhapatnam which will entail a cost of Rs 100 crore